The FDA Amendments Act of 2007 With more than a decade of experience accumulated, it is clear that the FDAAA introduced important improvements in the FDA’s capacity to track medication effects and mitigate risk. But challenges persist.
No takes yet. Share an insight, caveat, or question.
Avorn et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: